Parallax Volatility Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-43,877
Closed -$204K 1764
2024
Q4
$204K Buy
43,877
+42,443
+2,960% +$233K ﹤0.01% 1666
2024
Q3
$9.95K Buy
+1,434
New +$11.3K ﹤0.01% 1928
2022
Q1
Sell
-34,741
Closed -$1.14M 3057
2021
Q4
$1.14M Buy
34,741
+26,133
+304% +$1.05M ﹤0.01% 1852
2021
Q3
$353K Sell
8,608
-82,317
-91% -$2.99M ﹤0.01% 2359
2021
Q2
$3.27M Buy
90,925
+54,951
+153% +$2.03M ﹤0.01% 1442
2021
Q1
$1.4M Sell
35,974
-1,576
-4% -$70.9K ﹤0.01% 1918
2020
Q4
$1.51M Buy
+37,550
New +$1.73M ﹤0.01% 2007

Other funds holding GDRX

Parallax Volatility Advisers's GDRX Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 43,877 shares — an estimated $204K sold.

Parallax Volatility Advisers first reported a position in GDRX in Q4 2020 and held it in 7 quarters. The position peaked at $3.27M in Q2 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 43,877 GoodRx Holdings shares in Q1 2025, an estimated $204K.
  • Parallax Volatility Advisers first reported a position in GoodRx Holdings in Q4 2020 and held it in 7 quarters.
  • Parallax Volatility Advisers's GoodRx Holdings position peaked at $3.27M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.